These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30831203)

  • 1. Editorial to the mini-review series on relaxin, related peptides and receptors?
    Klonisch T
    Mol Cell Endocrinol; 2019 May; 487():1. PubMed ID: 30831203
    [No Abstract]   [Full Text] [Related]  

  • 2. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies.
    Ma S; Gundlach AL
    Adv Exp Med Biol; 2007; 612():119-37. PubMed ID: 18161485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relaxin 2--a pregnancy hormone involved in the process of carcinogenesis].
    Domińska K
    Ginekol Pol; 2013 Feb; 84(2):126-30. PubMed ID: 23668059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin family peptides and their receptors.
    Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
    Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human relaxin-2: historical perspectives and role in cancer biology.
    Nair VB; Samuel CS; Separovic F; Hossain MA; Wade JD
    Amino Acids; 2012 Sep; 43(3):1131-40. PubMed ID: 22855207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relaxin peptide family--structure, function and clinical applications.
    Chan LJ; Hossain MA; Samuel CS; Separovic F; Wade JD
    Protein Pept Lett; 2011 Mar; 18(3):220-9. PubMed ID: 20858209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
    Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
    Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
    Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.
    Sasser JM
    Am J Physiol Regul Integr Comp Physiol; 2013 Sep; 305(6):R559-65. PubMed ID: 23883673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin family peptide systems and the central nervous system.
    Callander GE; Bathgate RA
    Cell Mol Life Sci; 2010 Jul; 67(14):2327-41. PubMed ID: 20213277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using paleogenomics to study the evolution of gene families: origin and duplication history of the relaxin family hormones and their receptors.
    Yegorov S; Good S
    PLoS One; 2012; 7(3):e32923. PubMed ID: 22470432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the signaling system in relaxin-family peptides.
    Hsu SY; Semyonov J; Park JI; Chang CL
    Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
    Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
    Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the mouse and rat relaxin receptors.
    Scott DJ; Layfield S; Riesewijk A; Morita H; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():8-12. PubMed ID: 15956680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxin, the relaxin-like factor and their receptors.
    Schwabe C; Büllesbach EE
    Adv Exp Med Biol; 2007; 612():14-25. PubMed ID: 18161478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.
    Kocan M; Ang SY; Summers RJ
    Neurochem Res; 2016 Mar; 41(3):610-9. PubMed ID: 26294284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the primary hormone-binding site of RXFP1 and RXFP2.
    Scott DJ; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
    Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.